BACKGROUND:Biliary decompression with antibiotic therapy is the mainstay treatment for acute cholangitis with bacteremia. A few studies have been conducted to investigate the optimal duration and route of antibiotic therapy in biliary tract infection with bacteremia. METHODS:Patients with acute cholangitis with bacteremia who achieved successful biliary drainage were randomly assigned to an early oral antibiotic switch group (group A, n = 29) and a conventional intravenous antibiotics group (group B, n = 30). Patients were discharged when they were afebrile over 2 days after oral antibiotic switch and showed consecutive improvement in the laboratory index. They were followed up and assessed at 30 days after diagnosis to evaluate the eradication of bacteria, recurrence of acute cholangitis, and 30-day mortality rate. RESULTS: There were no statistically significant differences between the two groups in baseline characteristics, clinical and laboratory index, severity of acute cholangitis, bacteria isolated from blood cultures, and clinical outcomes. The rate of eradication of bacteria was 93.1 % in group A and 93.3 % in group B, respectively (p = 0.97). Using non-inferiority tests, the rate of eradication of bacteria in group A was not inferior to that in group B (95 % CI -0.13 to 0.14, p = 0.97). There was no statistically significant difference in the recurrence of acute cholangitis and a 30-day mortality rate between the two groups. CONCLUSIONS: Early switch to oral antibiotic therapy following adequate biliary drainage for treatment of acute cholangitis with bacteremia was not inferior to conventional 10-day intravenous antibiotic therapy.
RCT Entities:
BACKGROUND: Biliary decompression with antibiotic therapy is the mainstay treatment for acute cholangitis with bacteremia. A few studies have been conducted to investigate the optimal duration and route of antibiotic therapy in biliary tract infection with bacteremia. METHODS:Patients with acute cholangitis with bacteremia who achieved successful biliary drainage were randomly assigned to an early oral antibiotic switch group (group A, n = 29) and a conventional intravenous antibiotics group (group B, n = 30). Patients were discharged when they were afebrile over 2 days after oral antibiotic switch and showed consecutive improvement in the laboratory index. They were followed up and assessed at 30 days after diagnosis to evaluate the eradication of bacteria, recurrence of acute cholangitis, and 30-day mortality rate. RESULTS: There were no statistically significant differences between the two groups in baseline characteristics, clinical and laboratory index, severity of acute cholangitis, bacteria isolated from blood cultures, and clinical outcomes. The rate of eradication of bacteria was 93.1 % in group A and 93.3 % in group B, respectively (p = 0.97). Using non-inferiority tests, the rate of eradication of bacteria in group A was not inferior to that in group B (95 % CI -0.13 to 0.14, p = 0.97). There was no statistically significant difference in the recurrence of acute cholangitis and a 30-day mortality rate between the two groups. CONCLUSIONS: Early switch to oral antibiotic therapy following adequate biliary drainage for treatment of acute cholangitis with bacteremia was not inferior to conventional 10-day intravenous antibiotic therapy.
Authors: Anja U G van Lent; Joep F W M Bartelsman; Guido N J Tytgat; Peter Speelman; Jan M Prins Journal: Gastrointest Endosc Date: 2002-04 Impact factor: 9.427
Authors: J W Chow; M J Fine; D M Shlaes; J P Quinn; D C Hooper; M P Johnson; R Ramphal; M M Wagener; D K Miyashiro; V L Yu Journal: Ann Intern Med Date: 1991-10-15 Impact factor: 25.391
Authors: R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; M M Levy Journal: Intensive Care Med Date: 2004-03-03 Impact factor: 17.440
Authors: Noah Wald-Dickler; Paul D Holtom; Matthew C Phillips; Robert M Centor; Rachael A Lee; Rachel Baden; Brad Spellberg Journal: Am J Med Date: 2021-10-27 Impact factor: 4.965
Authors: Philipp A Reuken; Dorian Torres; Michael Baier; Bettina Löffler; Christoph Lübbert; Norman Lippmann; Andreas Stallmach; Tony Bruns Journal: PLoS One Date: 2017-01-11 Impact factor: 3.240
Authors: Omer Al-Yahri; Raed M Al-Zoubi; Azza Alam Elhuda; Amina Ahmad; Mahmood Al Dhaheri; Sherif Abdelaziem; Mustafa Alwani; Ahmad R Al-Qudimat; Ahmad Zarour Journal: Int J Surg Protoc Date: 2022-03-02
Authors: Sylke Haal; Britt Ten Böhmer; Sebastiaan Balkema; Annekatrien Ctm Depla; Paul Fockens; Jeroen M Jansen; Sjoerd D Kuiken; Boris I Liberov; Ellert van Soest; Jeanin E van Hooft; Elske Sieswerda; Rogier P Voermans Journal: United European Gastroenterol J Date: 2020-03-17 Impact factor: 4.623
Authors: Sylke Haal; Mattheus C B Wielenga; Paul Fockens; Charlotte A Leseman; Cyriel Y Ponsioen; Ellert J van Soest; Roy L J van Wanrooij; Elske Sieswerda; Rogier P Voermans Journal: Dig Dis Sci Date: 2021-01-19 Impact factor: 3.199